JP2009514786A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514786A5
JP2009514786A5 JP2008521643A JP2008521643A JP2009514786A5 JP 2009514786 A5 JP2009514786 A5 JP 2009514786A5 JP 2008521643 A JP2008521643 A JP 2008521643A JP 2008521643 A JP2008521643 A JP 2008521643A JP 2009514786 A5 JP2009514786 A5 JP 2009514786A5
Authority
JP
Japan
Prior art keywords
composition
meq
citrate
calcium
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008521643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514786A (ja
Filing date
Publication date
Priority claimed from US11/183,140 external-priority patent/US20070077314A1/en
Application filed filed Critical
Publication of JP2009514786A publication Critical patent/JP2009514786A/ja
Publication of JP2009514786A5 publication Critical patent/JP2009514786A5/ja
Pending legal-status Critical Current

Links

JP2008521643A 2005-07-15 2006-07-13 腎結石及び骨粗鬆症の処置のためのクエン酸カリウムカルシウムの粉末混合物 Pending JP2009514786A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/183,140 US20070077314A1 (en) 2005-07-15 2005-07-15 Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
PCT/US2006/027398 WO2007011740A2 (en) 2005-07-15 2006-07-13 A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

Publications (2)

Publication Number Publication Date
JP2009514786A JP2009514786A (ja) 2009-04-09
JP2009514786A5 true JP2009514786A5 (enExample) 2009-06-25

Family

ID=37669400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008521643A Pending JP2009514786A (ja) 2005-07-15 2006-07-13 腎結石及び骨粗鬆症の処置のためのクエン酸カリウムカルシウムの粉末混合物

Country Status (5)

Country Link
US (2) US20070077314A1 (enExample)
EP (1) EP1922064A4 (enExample)
JP (1) JP2009514786A (enExample)
AU (1) AU2006270162B2 (enExample)
WO (1) WO2007011740A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage
US9529465B2 (en) * 2013-12-02 2016-12-27 At&T Intellectual Property I, L.P. Secure interaction with input devices
US20150216825A1 (en) * 2014-02-06 2015-08-06 University Of Houston System Organic acids as growth inhibitors of pathological calcification and uses thereof
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
CN104069125B (zh) * 2014-07-16 2017-02-08 华南理工大学 一种用于泌尿系磷酸盐结石的溶石剂及其制备方法
WO2016159897A1 (en) * 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
WO2019035989A1 (en) * 2017-08-17 2019-02-21 The Board Of Regents Of The University Of Texas System PREVENTION OF CALCIUM OXALATE RENAL CALCULATIONS BY POTASSIUM HYDROXYCITRATE
IT202200021258A1 (it) * 2022-10-14 2024-04-14 Neilos S R L “Composizione nutraceutica o farmaceutica per il benessere renale”

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888182A (en) * 1983-04-11 1989-12-19 Board Of Regents Of The University Of Texas System Compositions and methods of treating calcium renal stones
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
US4722847A (en) * 1986-05-07 1988-02-02 The Procter & Gamble Company Fruit juice beverages and juice concentrates nutritionally supplemented with calcium
US4871554A (en) * 1987-08-12 1989-10-03 Coca-Cola Company Calcium fortified food product
US5128374A (en) * 1987-08-28 1992-07-07 The Procter & Gamble Company Use of calcium citrate malate for the treatment of osteoporosis and related disorders
ES2061394B1 (es) * 1993-02-05 1995-06-16 Robert S A Lab Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada.
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
GB9603518D0 (en) * 1996-02-20 1996-04-17 Smithkline Beecham Plc Novel process
US6287607B2 (en) * 1999-07-19 2001-09-11 Mission Pharmacal Company Potassium calcium citrate compositions and methods therefor
US6599544B2 (en) * 2000-01-26 2003-07-29 American Micronutrients, Inc. Calcium enrichment composition and method for producing the same
BR0114988A (pt) * 2000-10-16 2004-02-03 Pepsico Inc Bebidas suplementadas com cálcio e métodos para fabricá-las
US20030175360A1 (en) * 2002-02-22 2003-09-18 Renzo Luzzatti Symptomatic relief of gastrointestinal disorders
US7507421B2 (en) * 2002-04-30 2009-03-24 Unibar Corporation Hydroxycitric acid salt composition and method of making
US6833146B2 (en) * 2002-07-08 2004-12-21 Unilab Pharmatech, Ltd. Powered beverage mix with rapidly dissolving calcium
US7138151B2 (en) * 2002-11-22 2006-11-21 Unilab Pharmatech, Ltd. Calcium-fortified acidic beverages
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency

Similar Documents

Publication Publication Date Title
JP2011500711A5 (enExample)
RU2004108111A (ru) Пленка, освежающая дыхание
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
JP2002523475A5 (enExample)
RU2004134728A (ru) Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
JP2005530743A5 (enExample)
JP2010513487A5 (enExample)
MXPA05008033A (es) Composiciones de milnacipran en forma de multiparticulas para administracion oral.
RU2007103154A (ru) Адсорбент фосфата на основе сульфата железа
RU2017143849A (ru) Твёрдый состав для перорального применения, содержащий иринотекан, и способ его получения
JP2019081811A5 (enExample)
JP2009514786A5 (enExample)
JP2005507883A5 (enExample)
RU2016138577A (ru) Жидкая фармцевтическая композиция
AU2014227598B2 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
JPS58183607A (ja) 歯科用セメント
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
JP2006521995A5 (enExample)
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
AU2006270162B2 (en) A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
JP2014504628A5 (enExample)
RU2011108370A (ru) Жевательная композиция, включающая альгинат, бикарбонат и карбонат
RU2017114677A (ru) Перорально распадающаяся твердая фармацевтическая единица дозирования, содержащая контролирующее родовую деятельность вещество
BR0206371A (pt) Composição farmacêutica sólida solúvel em água não efervescente, composição farmacêutica lìquida oral, e, processo para a fabricação de uma composição granulada
WO2007038274A3 (en) Effervescent oral care compositions and methods of use